- ICH GCP
- Registro de ensaios clínicos dos EUA
- Ensaio Clínico NCT03119792
Salud Integral Colombia
Salud Integral Colombia (SI! Colombia II).
Visão geral do estudo
Status
Condições
Intervenção / Tratamento
Descrição detalhada
Cardiovascular disease (CVD) is a leading cause of mortality worldwide. Negative health behaviors initiated in childhood that persist through adulthood can be risk factors that predict CVD. In Colombia, poor lifestyle factors affecting childhood are very prevalent: 50% live a sedentary lifestyle, 48% have high fat and carbohydrate consumption, 30% are exposed to passive smoking, 14% are overweight or obese, 15.8% have hypercholesteremia, and 5% have hypertension.
Negative health behaviors initiated in childhood that persist through adulthood can be risk factors that predict CVD. In Colombia, poor lifestyle factors affecting childhood are very prevalent: 50% live a sedentary lifestyle, 48% have high fat and carbohydrate consumption, 30% are exposed to passive smoking, 14% are overweight or obese, 15.8% have hypercholesterolemia, and 5% have hypertension. In May 2009, in Bogota, Colombia, was conducted a cluster randomized trial (kindergartens) in 1216 children between 3 and 6 years old, and 928 parents with the aim of evaluate a five months educational intervention to change knowledge, attitudes and habits related to a healthy diet and active lifestyle in preschoolers. The results showed that the intervention was feasible and effective . Finally every 1216 children "cohort Usaquén" received the intervention, performing a follow-up at 18 and 36 months showing that the changes persisted over time
In 2016 the SI! Program will perform a new follow up of this cohort, in children between 9 and 13 years old, and under the assumption that the effects of this intervention have decreased, the researchers plan to evaluate through a randomized control trial the impact of a four months community educational intervention, in the cardiovascular health of these children and in knowledge, attitudes, habits and emotions towards a healthy lifestyle. The study will include children from the Usaquen´s cohort who are contacted and children of a comparable cohort (n = 1200), in order to achieve sustainable changes in the cardiovascular health of children, that impact the burden of disease in their adulthood.
Due to the high rate of migration within the country, given the social and economic difficulties faced by many Colombians, in 2015 the study population was scattered from 1 to 15 localities and from 14 kindergartens to more than 200 public and private schools, mostly in the Usaquen´s locality, with great variability ranging from the facilities, resources, length of the school day, number of children in each classroom, to the training of teachers and their low motivation and availability time to perform any initiative (data obtained from focus groups conducted in schools). For these reasons, it is not feasible to carry out a second educational intervention in schools. However, the investigators believe that a community-based intervention is an excellent choice for tracking this population.
The objective of this project is two-fold. First, it is to assess differences at baseline in healthy lifestyles between children from Usaquen's cohort and a comparable cohort. The study will also assess differences at baseline in cardiovascular health between parents from Usaquen's cohort, and a comparable cohort. Second, it is to assess the impact of a community pedagogical intervention in healthy lifestyles in children nine to thirteen years old.
Tipo de estudo
Inscrição (Real)
Estágio
- Não aplicável
Contactos e Locais
Locais de estudo
-
-
-
Bogota, Colômbia
- Fundación Cardioinfantil Instituto de Cardiología
-
-
Critérios de participação
Critérios de elegibilidade
Idades elegíveis para estudo
Aceita Voluntários Saudáveis
Gêneros Elegíveis para o Estudo
Descrição
Inclusion Criteria:
- Children 9-13 years old from the original Usaquen's cohort
- Children 9-13 years old who are not included in the original cohort (comparable cohort)
- Parents of participating children
Exclusion Criteria:
- Participant unable to consent
- Parents of non-participating children
- Siblings of the Original Usaquen cohort's children that do not belong to the original cohort
Plano de estudo
Como o estudo é projetado?
Detalhes do projeto
- Finalidade Principal: Prevenção
- Alocação: Randomizado
- Modelo Intervencional: Atribuição Paralela
- Mascaramento: Nenhum (rótulo aberto)
Armas e Intervenções
Grupo de Participantes / Braço |
Intervenção / Tratamento |
|---|---|
|
Experimental: Investigational
An education intervention will be implemented for 600 children from the original cohort (300) and comparable cohort (300) over a four month period at community centers.
These sessions will occur twice a month on the weekends.
The education intervention will help increase the children's knowledge of attitudes, and habits of healthy lifestyles.
|
The education intervention will help increase the children's knowledge of attitudes, and habits of healthy lifestyles.
The program will cover self care of the body and heart, emotional management, healthy diet, and physical activity.
|
|
Comparador Ativo: Control
The control group will consist of 600 children from the original cohort (300) and comparable cohort (300).
The control group will meet twice a month for four months at community centers.
During these sessions, investigators will teach a curriculum that is not related to knowledge, attitudes, and habits towards healthy lifestyles.
|
The control will not receive an education program relating to knowledge, attitudes, nor habits of healthy lifestyles.
Instead, these sessions will occur twice a month, and will last an hour and forty-five minutes.
The control program is titled "Life's Challenges", which will focus on helping children develop skills necessary for day to day life, is divided into four modules: Person, Family, School, and Environment.
There will be four different types of activities used throughout the program including: "Lets Think," "Lets Experiment," "We will finish with...or synthesis," and "Not here."
|
O que o estudo está medindo?
Medidas de resultados primários
Medida de resultado |
Descrição da medida |
Prazo |
|---|---|---|
|
Change in Ideal Cardiovascular Health Score (ICH)
Prazo: Baseline and 6 months
|
Using the metrics and criteria for individual ideal health factors and behaviors, the ideal cardiovascular health score (ICH) will be calculated for each metric (poor=0, intermediate=1, ideal=2 points; range=0-14 points for all seven metrics) and categorized them into three groups: poor (0-4 points), intermediate (5-9 points), and ideal (10-14 points).
Higher values represent a better outcome.
|
Baseline and 6 months
|
|
Change in KAH score in Children of the Original and Comparable Cohort
Prazo: Baseline and 6 months
|
Mean and standard deviation of the score of knowledge, attitudes, habits and emotions towards a healthy lifestyle in children will be determined, calculating the difference found between the baseline measurement and the measurement at the end of the study in intervened and control groups in the Original and comparable cohort.
Possible differences between changes in means will be assessed using test t-test.
Multi-variable models will be performed to adjust for potential con-founders.
|
Baseline and 6 months
|
Medidas de resultados secundários
Medida de resultado |
Descrição da medida |
Prazo |
|---|---|---|
|
Change in ICH score in Children of the Original and Comparable Cohort
Prazo: Baseline and 6 months
|
Mean difference in scores and standard deviations in cardiovascular health (ICH) at the end of the study between intervened children in the Usaquen´s cohort and intervened children in the comparable cohort, will be determined, using a t-test.
Multivariable models will be performed to adjust for potential confounders.
The prevalence (CI 95%) of each of the 7 components of cardiovascular health rated as poor (risk factor) will be determined, calculating the difference found between the baseline measurement and the measurement at the end of the study in intervened children in the Usaquen´s cohort and intervened children in the comparable cohort.
Possible differences between changes in prevalences will be evaluated using the chi-squared test.
|
Baseline and 6 months
|
|
Change in KAH score in Children of the Usaquen Cohort and Comparable Cohort
Prazo: Baseline and 6 months
|
Mean and standard deviation of the score of knowledge, attitudes, habits and emotions towards a healthy lifestyle will be determined, calculating the difference found between the baseline measurement and the measurement at the end of the study in intervened children in the Usaquen´s cohort and intervened children in the comparable cohort.
Multivariable models will be performed to adjust for potential confounders.
Possible differences between changes in means will be assessed using a t-test.
|
Baseline and 6 months
|
|
Change in ICH score in Parents of the Original and Comparable Cohort
Prazo: Baseline and 6 months
|
In parents, mean difference in scores and standard deviations in cardiovascular health (ICH) at the end of the study between intervened and control groups will be determined, using a t-test, differentiating between parents in the Usaquén´s cohort and a comparable cohort.
Multivariable models will be performed to adjust for potential confounders.
The prevalence (CI 95%) of each of the 7 components of cardiovascular health rated as poor (risk factor) will be determined, calculating the difference found between the baseline measurement and the measurement at the end of the study in intervened and control groups differentiating between parents in the Usaquén´s cohort and a comparable cohort.
Possible differences between changes in prevalences will be evaluated using the chi-square test.
|
Baseline and 6 months
|
Colaboradores e Investigadores
Patrocinador
Colaboradores
Investigadores
- Cadeira de estudo: Jorge Baxter, PhD, Mobilizarte Social
- Diretor de estudo: Jaime Cespedes, MD, Fundación CardioInfantil de Cardiologia
Publicações e links úteis
Datas de registro do estudo
Datas Principais do Estudo
Início do estudo
Conclusão Primária (Real)
Conclusão do estudo (Real)
Datas de inscrição no estudo
Enviado pela primeira vez
Enviado pela primeira vez que atendeu aos critérios de CQ
Primeira postagem (Real)
Atualizações de registro de estudo
Última Atualização Postada (Real)
Última atualização enviada que atendeu aos critérios de controle de qualidade
Última verificação
Mais Informações
Termos relacionados a este estudo
Palavras-chave
Outros números de identificação do estudo
- GCO 16-1354
Plano para dados de participantes individuais (IPD)
Planeja compartilhar dados de participantes individuais (IPD)?
Informações sobre medicamentos e dispositivos, documentos de estudo
Estuda um medicamento regulamentado pela FDA dos EUA
Estuda um produto de dispositivo regulamentado pela FDA dos EUA
Essas informações foram obtidas diretamente do site clinicaltrials.gov sem nenhuma alteração. Se você tiver alguma solicitação para alterar, remover ou atualizar os detalhes do seu estudo, entre em contato com register@clinicaltrials.gov. Assim que uma alteração for implementada em clinicaltrials.gov, ela também será atualizada automaticamente em nosso site .
Ensaios clínicos em Saúde cardiovascular
-
University of Dublin, Trinity CollegeDesconhecidoAtletas de elite aposentados da Brain Health
-
Queens College, The City University of New YorkRecrutamentoPublicação de artigos submetidos ao American Journal of Public HealthEstados Unidos
-
WestatPlasma Protein Therapeutics AssociationAinda não está recrutandoHealth Effects (Níveis de Ferritina, Níveis de PCR, Níveis de iGg, Saúde Auto-reportada)Estados Unidos
-
The Mediterranean Institute for the Advance of...Carlos III Health Institute; European Regional Development Fund; Andalusian Regional... e outros colaboradoresAinda não está recrutandoDepressão | Ansiedade | Prevenção | m-healthEspanha
-
Mayo ClinicConcluídoRisco Cardiovascular | Prevenção CardiovascularEstados Unidos
-
Alliance For Medical Research in AfricaInstitut Pasteur de DakarAtivo, não recrutandoCâncer | Mortalidade | Cardiovascular | Doença cardiovascularSenegal
-
Martha BiddleInscrevendo-se por conviteRisco Cardiovascular | Redução do Risco CardiovascularEstados Unidos
-
IRCCS Policlinico S. DonatoIRCCS San Raffaele; Fondazione Policlinico Universitario Agostino Gemelli IRCCS e outros colaboradoresRecrutamentoRisco Cardiovascular | Risco cardiovascular genéticoItália
-
Fu Jen Catholic UniversityRecrutamentoDoença cardiovascular | Cirurgia CardiovascularTaiwan
-
University of DelawareAtivo, não recrutandoFator de Risco Cardiovascular | Saúde cardiovascularEstados Unidos
Ensaios clínicos em Education Intervention
-
University of TurkuDesconhecidoSaudável | Comportamento de saúdeFinlândia
-
Ege Miray TopcuConcluídoAnsiedade | Cuidados de suporte liderados por enfermeiras | Intervenções de enfermagemTurquia (Türkiye)
-
Istanbul Sabahattin Zaim UniversityConcluídoEpilepsia | Terapia medicamentosa | Estigma | Auto GerenciamentoPeru
-
Centre for Addiction and Mental HealthCanadian Institutes of Health Research (CIHR)ConcluídoDistúrbio de saúde mental | Uso de substânciasCanadá
-
Marmara UniversityAinda não está recrutandoInfertilidade | Auto-eficácia | Tecnologia de Reprodução Assistida | Infertilidade em Mulheres Submetidas a Tratamento de Reprodução Assistida | Comportamentos de Estilo de Vida SaudávelTurquia (Türkiye)
-
UNC Lineberger Comprehensive Cancer CenterNational Cancer Institute (NCI); Virginia Commonwealth UniversityRecrutamentoObesidade | Câncer | Atividade física | Dieta | Sobrevivência ao CâncerEstados Unidos
-
Nordsjaellands HospitalLund University; Region Capital Denmark; Ostfold University College; University... e outros colaboradoresRecrutamentoHospitalDinamarca, Noruega, Suécia
-
Stanford UniversityNational Institute on Aging (NIA)Ativo, não recrutando
-
Henry Ford Health SystemBlue Cross Blue Shield of Michigan FoundationConcluído
-
Munich Municipal HospitalTechnical University of Munich; University of RegensburgDesconhecidoInfarto CerebralAlemanha